Zhengye Biotechnology Holding (ZYBT) Non-Current Assets (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Non-Current Assets data on file, last reported at $42.2 million in Q4 2025.

• Non-Current Assets for Q4 2025 came in at $42.2 million, down 4.06% year-over-year; the trailing twelve-month figure through Dec 2025 was $42.2 million (down 4.06% YoY), and the FY2025 annual result was $42.8 million, down 1.13% from the prior year.
• Non-Current Assets steadied at $42.2 million in Q4 2025 per ZYBT's latest filing, from $42.3 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $43.9 million in Q4 2024 and troughed at $42.2 million in Q4 2025.
• A 3-year average of $42.9 million and a median of $42.7 million in 2023 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets rose 1.86% in 2024, then declined 4.06% in 2025.
• A 3-year view of Non-Current Assets shows it stood at $43.1 million in 2023, then climbed by 1.86% to $43.9 million in 2024, then retreated by 4.06% to $42.2 million in 2025.
• Business Quant data shows ZYBT's Non-Current Assets at $42.2 million in Q4 2025, $42.3 million in Q2 2025, and $43.9 million in Q4 2024.